<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression profile of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> reflects the unique genetic alterations present and is predictive of the clinical and biological characteristics of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Novel techniques have been developed to determine the global gene expression pattern of <z:mpath ids='MPATH_458'>normal</z:mpath> and neoplastic tissues </plain></SENT>
<SENT sid="2" pm="."><plain>A cDNA microarray uniquely suitable for the analysis of B-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (B-NHL) has been developed and preliminary analysis on diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) and B-<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) has been performed </plain></SENT>
<SENT sid="3" pm="."><plain>These studies indicate that: 1) it is feasible to determine the gene expression profiles of archival <z:hpo ids='HP_0002665'>lymphoma</z:hpo> samples frozen and stored in a clinical setting, 2) the expression profile of these 3 types of <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> are distinctive, 3) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> can be divided into at least 2 major subgroups according to their pattern of expression of B-cell associated genes and 4) the gene expression patterns in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> appear to have prognostic significance </plain></SENT>
<SENT sid="4" pm="."><plain>A larger study of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> is currently underway to confirm and extend our findings </plain></SENT>
<SENT sid="5" pm="."><plain>Gene expression profiles will be correlated with cytogenetic and clinical data to identify distinctive profiles that are of clinical and biological significance and to delineate key genetic lesions that determine these profiles </plain></SENT>
<SENT sid="6" pm="."><plain>The new information will allow the design of a simpler and less expensive array for clinical use </plain></SENT>
<SENT sid="7" pm="."><plain>The diagnostic array could provide rapid molecular characterization of every B-NHL at presentation for optimal treatment decisions and prognostication </plain></SENT>
<SENT sid="8" pm="."><plain>It is anticipated that this project will advance our understanding of the molecular mechanisms in the <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> of B-lymphoid cells and the new insights will help to identify promising molecular targets for therapeutic intervention </plain></SENT>
</text></document>